72922-69-1

Upstream product

• 34696-31-6 methyl 3,5-bis(benzyloxy)-4-methylbenzoate 
• 74-88-4 methyl iodide 
• 75238-29-8 3,5-dihydroxy-4-methylbenzoic acid methyl ester 
• 28026-96-2 3,5-dihydroxy-4-methylbenzoic acid 
• 69660-38-4 5-Hydroxy-3-methoxy-4-methylbenzoesaeure-methylester 
• 100-39-0 benzyl bromide 

Downstream Products

• 301530-15-4 3-(benzyloxy)-5-methoxy-4-methylbenzaldehyde 
• 301530-16-5 3-benzyloxy-5-methoxy-4-methylstyrene 

Relevant academic research and scientific papers

Preparation of tricyclic analog as CDE ring model of renieramycin marine natural product by novel photo-induced transformation of 6-methoxy-1,2,3,4-tetrahydroisoquinoline-5,8-dione

2-Acetyl-6-[(benzyloxy)methyl]-9-methoxy-8-methyl-11,11adihydro-2H-pyrazino[1,2-b]isoquinoline-1,4,7,10(3H,6H)-tetraone (11a) was prepared as the CDE ring model of renieramycins, and its novel photo-induced transformation was demonstrated to construct a 1,3-dioxol ring.

Approaches to the fully functionalized DEF ring system of ristocetin A via highly selective ruthenium-promoted SNAr reaction

Ruthenium-promoted intramolecular SNAr reaction has allowed the construction of the fully functionalized 16-membered DEF macrocycle 4 of ristocetin A that incorporates the required arylglycine and arylserine residues as the F and E ring, respectively.